Fields Ryan C, Meyers Bryan F
Division of Cardiothoracic Surgery, Barnes-Jewish Hospital, Washington University Medical Center, St. Louis, Missouri 63110-1013, USA.
Semin Thorac Cardiovasc Surg. 2006 Summer;18(2):85-91. doi: 10.1053/j.semtcvs.2006.06.005.
Sublobar resection has been utilized as an alternative to lobectomy for the treatment of early-stage lung cancer in patients with compromised preoperative pulmonary function. Early data have suggested higher rates of local recurrence and increased late mortality for sublobar resection as compared with lobectomy. Subsequent studies have been mixed with respect to outcomes. Here we review the existing literature comparing sublobar resection to lobectomy with respect to oncologic and pulmonary outcomes. We also discuss the effect of adjuvant intraoperative brachytherapy to sublobar resection and summarize ongoing clinical trials that compare sublobar resection to sublobar resection plus adjuvant brachytherapy in the treatment of early-stage lung cancer. Finally, based on the current evidence, we provide recommendations as to when sublobar resection might be considered in the treatment of lung cancer.
对于术前肺功能受损的早期肺癌患者,亚肺叶切除已被用作肺叶切除的替代治疗方法。早期数据表明,与肺叶切除相比,亚肺叶切除的局部复发率更高,晚期死亡率增加。随后的研究结果不一。在此,我们回顾了将亚肺叶切除与肺叶切除在肿瘤学和肺部结局方面进行比较的现有文献。我们还讨论了术中辅助近距离放疗对亚肺叶切除的影响,并总结了正在进行的比较亚肺叶切除与亚肺叶切除加辅助近距离放疗治疗早期肺癌的临床试验。最后,基于目前的证据,我们就何时可考虑将亚肺叶切除用于肺癌治疗提供建议。